We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock

Delisted

CERE was delisted on the 31st of July, 2024.

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 2312 (-229)

100% less funds holding in top 10

Funds holding in top 10: 160 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
1
Reduced
1
Closed
228
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
126
Chicago Capital Management
Illinois
-$1.61M -39,437 Closed
VOYA Investment Management
127
VOYA Investment Management
Georgia
-$1.4M -34,210 Closed
TRCT
128
Tower Research Capital (TRC)
New York
-$1.35M -33,086 Closed
PA
129
Profund Advisors
Maryland
-$1.33M -32,547 Closed
SO
130
STRS Ohio
Ohio
-$1.28M -31,316 Closed
Treasurer of the State of North Carolina
131
Treasurer of the State of North Carolina
North Carolina
-$1.23M -30,010 Closed
Skandinaviska Enskilda Banken (SEB)
132
Skandinaviska Enskilda Banken (SEB)
Sweden
-$1.23M -30,000 Closed
SG Americas Securities
133
SG Americas Securities
New York
-$1.2M -29,424 Closed
VF
134
Virtu Financial
New York
-$1.03M -25,140 Closed
VAM
135
Vazirani Asset Management
New York
-$1.02M -25,000 Closed
DTL
136
Dynamic Technology Lab
Singapore
-$990K -24,220 Closed
Group One Trading
137
Group One Trading
Illinois
-$942K -23,041 Closed
BCM
138
BCK Capital Management
Connecticut
-$900K -22,000 Closed
Blackstone Inc
139
Blackstone Inc
New York
-$844K -20,651 Closed
ASRS
140
Arizona State Retirement System
Arizona
-$831K -20,332 Closed
ECU
141
Eisler Capital (US)
New York
-$831K -20,331 Closed
AQR Capital Management
142
AQR Capital Management
Connecticut
-$810K -19,816 Closed
Nomura Holdings
143
Nomura Holdings
Japan
-$785K -19,209 Closed
Handelsbanken Fonder
144
Handelsbanken Fonder
Sweden
-$756K -18,500 Closed
State Board of Administration of Florida Retirement System
145
State Board of Administration of Florida Retirement System
Florida
-$743K -18,160 Closed
Teacher Retirement System of Texas
146
Teacher Retirement System of Texas
Texas
-$652K -15,950 Closed
ProShare Advisors
147
ProShare Advisors
Maryland
-$631K -15,422 Closed
DC
148
Diametric Capital
Massachusetts
-$553K -13,517 Closed
Zurich Cantonal Bank
149
Zurich Cantonal Bank
Switzerland
-$539K -13,170 Closed
HT
150
Headlands Technologies
Illinois
-$516K -12,630 Closed

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.